Hua Zhang

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Hangzhou, CN (2015 - 2023)
Zhejiang, CN (2023)

Company Filing History:

Otis Elevator Company

Chint Solar (zhejiang) Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221488 - APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01 (2025-02-11),

2. 11780916 - GIPR antibody and GLP-1 fusion protein thereof, and pharmaceutical composition and application thereof (2023-10-10),

3. 11712470 - Human endothelin receptor antibody and use thereof (2023-08-01),

4. 11542336 - GCGR antibody and GLP-1 fusion protein thereof, pharmaceutical composition thereof and application thereof (2023-01-03),

5. 11292852 - Method for extracting RG-I-rich pectin (2022-04-05),

6. 11110143 - Method for preparing citrus-derived complex prebiotic agent and use of the same (2021-09-07),

7. 10869927 - Human endothelin receptor antibody and use thereof (2020-12-22),

8. 10485870 - Stable pharmaceutical solution formulation of GLP-1R antibody fusion protein (2019-11-26),

9. 10376581 - Human endothelin receptor antibody and use thereof (2019-08-13),

10. 10253103 - Antibody specifically binding to GLP-1R and fusion protein thereof with GLP-1 (2019-04-09),

11. 10189680 - Landing-door door lock device (2019-01-29),

12. 10059773 - Antibody specifically binding to GLP-1 R and fusion protein thereof with GLP-1 (2018-08-28),

13. 9023681 - Method of fabricating heterojunction battery (2015-05-05),

Title: Innovations and Contributions of Inventor Hua Zhang

Introduction

Hua Zhang is a prominent inventor based in Hangzhou, China, known for his significant contributions to the field of biotechnology. With a total of 13 patents to his name, he has made remarkable advancements in the development of pharmaceutical compositions and therapeutic methods.

Latest Patents

Among his latest patents are the APJ antibody and its fusion protein with Elabela, which are designed to treat, prevent, or alleviate symptoms of pulmonary arterial hypertension, pulmonary hypertension, and heart failure. Another notable patent includes the GIPR antibody and its fusion protein with GLP-1, aimed at addressing non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, type 2 diabetes, and obesity. These innovations highlight his commitment to improving health outcomes through targeted therapies.

Career Highlights

Hua Zhang has worked with Gmax Biopharm LLC and Zhejiang University, where he has been instrumental in advancing research and development in his field. His work has not only contributed to scientific knowledge but has also paved the way for new treatment options for various health conditions.

Collaborations

Some of his notable coworkers include Cheng Zhang and Shuqian Jing, who have collaborated with him on various projects, further enhancing the impact of their collective research efforts.

Conclusion

Hua Zhang's innovative work and dedication to biotechnology have led to significant advancements in pharmaceutical compositions and therapeutic applications. His contributions continue to influence the field and improve patient care.

This text is generated by artificial intelligence and may not be accurate.